Global gene expression analysis market is anticipated to grow at a considerable CAGR of 8.6% during the forecast period (2024-2031). The ongoing advancement in genomic testing due to increased focus on the genome to treat chronic genetic disorders is a key factor driving the global market. For instance, in February 2024, NanoString Technologies, Inc. announced the commercial availability of the CosMx Human 6K Discovery Panel, the first single-cell spatial panel enabling research scientists to measure over 6,000 RNA targets, representing nearly every human biological pathway.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/gene-expression-analysis-market
Further, in January 2024, Thermo Fisher Scientific announced a next-generation Invitrogen TaqMan Cells-to-CT Express Kit, offering simplified, scalable workflows for gene expression analysis that produce less plastic waste. With improved chemistry, the Cells-to-CT Express Kit helps facilitate the preparation of cell lysates for reverse transcription (RT) real-time PCR (qPCR) in just five minutes.
Furthermore, in June 2023, Sarepta Therapeutics, Inc. received the US FDA accelerated approval of ELEVIDYS (delandistrogene moxeparvovec-rokl), an adeno-associated virus-based gene therapy for the treatment of ambulatory pediatric patients aged 4 through 5 years with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene. This indication is approved under accelerated approval based on the expression of ELEVIDYS micro-dystrophin observed in patients treated with ELEVIDYS.
Global Gene Expression Analysis Market Report Segment
By Technology
- Polymerase Chain Reaction (PCR)
- Next Generation Sequencing (NGS)
- Microarray
By Product
- Instruments
- Reagents & Consumables
- Services
By End-User
- Drug Discovery and Development
- Diagnostic Laboratories
- Academic Research Centers
A full report of Gene Expression Analysis Market available @ https://www.omrglobal.com/industry-reports/gene-expression-analysis-market
Gene Expression Analysis Market Report Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Almac Group Ltd.
- Biodesix, Inc.
- Biospherex LLC
- Cepheid
- Cernostics, Inc.
- Hoffmann-La Roche Ltd
- General Electric Co.
- Genomic Health, Inc.
- Lunaphore Technologies S.A.
- Metabiomics Corp.
- Myriad Genetics, Inc.
- Novartis International AG
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
